证券代码：002690 证券简称：美亚光电 公告编号：2026-002 合肥美亚光电技术股份有限公司 关于部分限制性股票回购注销完成的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示： 一、2021年限制性股票激励计划已履行的相关审批程序 1、2021年10月31日，公司第四届董事会第九次会议审议通过了《<2021年 限制性股票激励计划（草案）>及其摘要的议案》、《<2021年限制性股票激励 计划实施考核管理办法>的议案》、《关于提请股东大会授权董事会办理公司 2021年限制性股票激励计划相关事项的议案》，公司第四届监事会第八次会议 审议通过了相关议案。公司独立董事就本次股权激励计划是否有利于公司的持 续发展及是否存在损害公司及全体股东利益的情形发表了独立意见。 2、2021年11月1日至2021年11月10日，公司对本激励计划首次授予激励对 象姓名和职务在公司内网进行了公示，截至公示期满，公司监事会未收到任何 人对本次拟激励对象提出任何异议或不良反馈。2021年11月12日，公司监事会 发布了《监事会关于公司2021年限制性股票激励计划首次授予激励 ...

Group 1 - The core point of the article is that Meiya Optoelectronics (002690) reported a total of 26,516 shareholders as of January 9, 2026 [1]

Core Viewpoint - Meiya Optoelectronics has shown a positive performance in both stock price and financial metrics, indicating potential growth opportunities in the optical detection and medical equipment sectors [1][2]. Group 1: Stock Performance and Financing - On January 9, Meiya Optoelectronics' stock rose by 1.18%, with a trading volume of 111 million yuan [1]. - The financing data for January 9 indicates a financing purchase amount of 15.11 million yuan, with a net financing purchase of 647,300 yuan [1]. - As of January 9, the total financing and securities lending balance for Meiya Optoelectronics was 161 million yuan, with the financing balance at 159 million yuan, representing 0.84% of the circulating market value [1]. Group 2: Financial Performance - For the period from January to September 2025, Meiya Optoelectronics achieved an operating income of 1.694 billion yuan, reflecting a year-on-year growth of 7.35% [2]. - The net profit attributable to the parent company for the same period was 519 million yuan, marking a year-on-year increase of 15.30% [2]. Group 3: Shareholder and Dividend Information - Since its A-share listing, Meiya Optoelectronics has distributed a total of 4.898 billion yuan in dividends, with 1.852 billion yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 3.36% to 26,000, while the average circulating shares per person increased by 3.48% to 16,658 shares [2][3]. - Notable changes in institutional holdings include Hong Kong Central Clearing Limited becoming the second-largest circulating shareholder, increasing its holdings by 10.17 million shares [3].

Core Viewpoint - Meiya Optoelectronics experienced a stock price decline of 2.04% on January 8, 2023, with a current price of 21.08 CNY per share and a market capitalization of 18.598 billion CNY [1] Group 1: Stock Performance - The stock price of Meiya Optoelectronics has increased by 2.48% year-to-date, with a 0.09% increase over the last five trading days, a 3.49% increase over the last 20 days, and a 5.93% increase over the last 60 days [1] - As of December 31, 2022, the number of shareholders decreased by 3.36% to 26,000, while the average circulating shares per person increased by 3.48% to 16,658 shares [2] Group 2: Financial Performance - For the period from January to September 2025, Meiya Optoelectronics reported a revenue of 1.694 billion CNY, representing a year-on-year growth of 7.35%, and a net profit attributable to shareholders of 519 million CNY, reflecting a year-on-year increase of 15.30% [2] - The company has distributed a total of 4.898 billion CNY in dividends since its A-share listing, with 1.852 billion CNY distributed over the last three years [3] Group 3: Shareholding Structure - As of September 30, 2025, Hong Kong Central Clearing Limited is the second-largest circulating shareholder, holding 61.9457 million shares, an increase of 10.1739 million shares from the previous period [3] - The fund "China Europe Value Select Mixed A" is a new entrant among the top ten circulating shareholders, holding 5.5127 million shares [3]

证券代码：002690 证券简称：美亚光电 公告编号：2026-001 合肥美亚光电技术股份有限公司 关于诉讼事项终审判决胜诉的自愿性披露公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈 述或者重大遗漏。 特别提示： 一、本次诉讼的基本情况 因商业秘密被非法侵害，公司于2020年8月向安徽省合肥市中级人民法院对登特菲及 林茂先、张鹏、尹传祥、曲洪岩、吴涛、张建波等6人提起诉讼。安徽省合肥市中级人民 法院于2023年9月作出（2020）皖01民初2241号民事判决，主要内容为：（1）所有被告即 日停止侵害公司的商业机密和技术信息；（2）被告登特菲自判决生效之日起15日内赔偿 公司经济损失2,101.57万元、合理维权支出95.854万元；（3）被告林茂先在登特菲应承 担的赔款项在500万元范围内承担连带赔偿责任，其他5人在50万元范围内承担连带赔偿责 任。因不服一审判决，公司、登特菲均向中华人民共和国最高人民法院提起上诉。详见公 司于2024年3月30日披露的《2023年年度报告》、2024年8月22日披露的《2024年半年度报 告》、2025年3月28日披露的《2024年年度报 ...

Core Viewpoint - Meiya Optoelectronics announced that, according to a document issued by the China Securities Depository and Clearing Corporation, the number of shareholders is expected to reach 26,050 by the close of trading on December 31, 2025 [2] Group 1 - The company is responding to investor inquiries on its interactive platform [2] - The projected number of shareholders indicates potential growth in investor interest [2]

Group 1 - The Anhui Provincial Health Commission and other authorities have released the first batch of "new quality drug and medical device" product catalog to accelerate the promotion and application of innovative medical products, fostering new productive forces in the biopharmaceutical industry [1] - A total of 60 "new quality drug and medical device" products were announced, with 45 products from Hefei, accounting for 75% of the total in the province, highlighting Hefei's strong innovation capabilities and industrial clustering effect [1] - In the biopharmaceutical sector, all three selected biopharmaceuticals in the province are from Hefei, including innovative drugs for tuberculosis/influenza prevention by Zhifei Longcom and anti-tumor drugs by Anke Bio [1] Group 2 - Hefei's Industrial and Information Technology Bureau is actively promoting the innovative development of the biopharmaceutical industry, focusing on building a collaborative industrial ecosystem involving government, industry, academia, research, application, and finance [2] - The city is nurturing local leading enterprises such as Anke Bio, Opcon Vision, and Meiya Optoelectronics while successfully attracting innovative companies like Ruisi Digital Technology through high-level platforms [2] - Collaboration with institutions like the University of Science and Technology of China and Anhui University of Traditional Chinese Medicine has led to the incubation of technology-based SMEs, creating a favorable development pattern for large, medium, and small enterprises [2]

Core Viewpoint - Meiya Optoelectronics (002690) has been focusing on three main sectors: food safety, medical imaging, and renewable resources, while continuously enhancing R&D investment and integrating advanced technologies such as AI, big data, IoT, and cloud computing into its core products [1] Group 1 - The company has developed intelligent product matrices including sorting machines for renewable resources, dental CBCT, grain sorting, and tea sorting, which effectively improve customer operational efficiency and benefits [1] - The integration of advanced technologies into main products is aimed at promoting digital and intelligent development within the industry [1]

Group 1 - The core point of the article is that Meiya Optoelectronics (002690) reported a total of 26,956 shareholders as of the market close on December 19 [1]

Core Viewpoint - As of December 10, 2025, the number of shareholders for Meiya Optoelectronics (002690) is reported to be 28,091 [1] Company Summary - Meiya Optoelectronics has engaged with investors through an interactive platform, providing transparency regarding its shareholder count [1] - The company is actively communicating with its investors, indicating a focus on shareholder engagement and investor relations [1]